CAR T cell therapy in solid tumors: A review of current clinical trials

Chimeric antigen receptor (CAR) T cell therapy has made tremendous strides in the arena of hematological malignancies with approved therapies in certain leukemias, lymphomas, and recently myeloma with overall highly favorable response rates. While numerous clinical studies are still ongoing for hema...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Urvi, Abernathy, John, Savani, Bipin N, Oluwole, Olalekan, Sengsayadeth, Salyka, Dholaria, Bhagirathbhai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175685/
https://www.ncbi.nlm.nih.gov/pubmed/35844304
http://dx.doi.org/10.1002/jha2.356

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175685/
https://www.ncbi.nlm.nih.gov/pubmed/35844304
http://dx.doi.org/10.1002/jha2.356

Ejemplares similares